RxDoctor Payments Data

Rachel Rome, MD

Interventional Pain Medicine · Hopkinsville, KYNPI 1679795256

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $320 and has fallen 66.3% since, to $108 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in KY, where the typical reported total is $3,169.

$733in general payments, 2019–2025

Across 32 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$166
  • Lilly USA, LLC$85
  • MDD US Operations, LLC$66
  • Lundbeck LLC$59
  • Organogenesis Inc.$56
  • Collegium Pharmaceutical, Inc.$52
  • plus $249 from 12 others

What the payments were for

  • Food & beverage$733100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$733 in reported general payments places this provider in the 20th percentile of 55 interventional pain medicine providers in Kentucky.

See all interventional pain medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$12,952
Medicare patients
42
Services billed
550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen46$1,524
Naloxone Hcl17$815
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$655
Morphine Sulfate ErMorphine Sulfate25$626
Oxycodone Hcl18$511
Gabapentin43$368
Pregabalin13$279
Tizanidine Hcl21$224
Cyclobenzaprine Hcl15$57

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Hopkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →